ArticleOPEN ACCESS

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?

Frontiers in Immunology
DOI: 10.3389/fimmu.2021.636375
6Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

In this review article we discuss the role of the memory T cells in multiple myeloma (MM) and how they may influence immune responses in patients that received immunomodulating drugs and check point therapy.

Author supplied keywords

Cite

CITATION STYLE

APA

Sponaas, A. M., Waage, A., Vandsemb, E. N., Misund, K., Børset, M., Sundan, A., … Standal, T. (2021, February 15). Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango? Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2021.636375

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free